HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women
Introduction: Using tenofovir disoproxil fumarate (TDF) is recommended in the 3rd trimester for pregnant women with HBV DNA ≥ 200,000 IU/mL to prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV). However, HBV DNA quantification is unavailable in many resource-limited areas worldw...
Saved in:
| Main Authors: | Minh Ngoc Nguyen, Thi Thu Huong Nguyen, Tran Dieu Hien Pham, Van Nghia Khuu, Quoc Cuong Hoang, Vu Thuong Nguyen, Ngoc Huu Tran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2023-10-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/17516 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
by: Hae Lim Lee, et al.
Published: (2025-07-01) -
Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings
by: Simmone D’souza, et al.
Published: (2025-03-01) -
Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
by: Yan Peng, et al.
Published: (2025-01-01) -
Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody
by: Ruifei Xue, et al.
Published: (2025-12-01) -
HBeAg clearance in chronic Hepatitis B: is it predictable?
by: Tuba İlgar, et al.
Published: (2025-06-01)